These datasupported the results of previous studies that suggestedthe delivery of NTFs, such as bFGF and BDNF induced abeneficial effect of clinical and pathological scores with anincrease of mature oligodendrocytes and their progenitorsin an EAE model of MS (34, 35). This evidence concerns the gene FGF2 and myeloid sarcoma.